CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.100
-0.070 (-3.23%)
Aug 7, 2025, 4:00 PM - Market closed

Chico's FAS Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
141.1138.1101.2153.1637.3168.43
Upgrade
Revenue Growth (YoY)
18.01%36.45%90.38%42.48%-45.47%154.36%
Upgrade
Gross Profit
141.1138.1101.2153.1637.3168.43
Upgrade
Selling, General & Admin
29.6329.7330.0240.4539.1636.03
Upgrade
Research & Development
68.3583.3877.68106.55114.19112.94
Upgrade
Operating Expenses
97.97113.11107.7147153.35148.97
Upgrade
Operating Income
43.1325-6.48-93.84-116.04-80.54
Upgrade
Interest & Investment Income
5.17.149.841.680.261.84
Upgrade
Currency Exchange Gain (Loss)
-0.04-0.04-0.030.34-0.08-0.03
Upgrade
Other Non Operating Income (Expenses)
0.04-----
Upgrade
EBT Excluding Unusual Items
48.2332.093.32-91.82-115.87-78.73
Upgrade
Merger & Restructuring Charges
----7.5--
Upgrade
Pretax Income
48.2332.093.32-99.32-115.87-78.73
Upgrade
Income Tax Expense
0.250.223.89---13.91
Upgrade
Net Income
47.9831.87-0.57-99.32-115.87-64.82
Upgrade
Net Income to Common
47.9831.87-0.57-99.32-115.87-64.82
Upgrade
Shares Outstanding (Basic)
978474666446
Upgrade
Shares Outstanding (Diluted)
978574666446
Upgrade
Shares Change (YoY)
17.52%14.82%12.27%2.48%39.01%1.79%
Upgrade
EPS (Basic)
0.500.38-0.01-1.51-1.81-1.40
Upgrade
EPS (Diluted)
0.490.38-0.01-1.51-1.81-1.40
Upgrade
Free Cash Flow
-77.68-86.54-56.88-112.53-120.642.95
Upgrade
Free Cash Flow Per Share
-0.80-1.02-0.77-1.71-1.880.06
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
30.56%18.10%-6.41%-176.50%-311.00%-117.70%
Upgrade
Profit Margin
34.01%23.08%-0.56%-186.82%-310.54%-94.73%
Upgrade
Free Cash Flow Margin
-55.05%-62.66%-56.19%-211.67%-323.33%4.31%
Upgrade
EBITDA
44.726.76-4.31-91.39-113.34-77.97
Upgrade
EBITDA Margin
31.68%19.38%-4.26%-171.91%--113.94%
Upgrade
D&A For EBITDA
1.571.772.182.442.712.57
Upgrade
EBIT
43.1325-6.48-93.84-116.04-80.54
Upgrade
EBIT Margin
30.56%18.10%-6.41%-176.50%--117.70%
Upgrade
Effective Tax Rate
0.52%0.70%117.12%---
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q